Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

潘競成 (Chin-Chen Pan)

潘競成(Chin-Chen Pan)圖 複診掛號 初診掛號

[Profile]

  • Education
    • Medicine, National Yang-Ming University
  • Career and Experience
    Current Positions：
    • 2022- 迄今 Taipei Veteran General Hospital, dept. of Pathology & Laboratory Medicine Director
    • 2004- 迄今 National Yang Ming Chiao Tung University Department of Pathology Professor
    • 2006- 迄今 Taiwan society of pathology Councillor
    Experiences：
    • 2019- 2022 Taipei Veteran General Hospital, dept. of Pathology & Laboratory Medicine Sections chief, Quality Assurance
    • 2015- 2019 International Society of Urologic Pathology International councillor Asia
    • - Taipei Veteran General Hospital, dept. of Pathology & Laboratory Medicine Professor, Faculty of Pathology; Sections chief, Surgical Pathology
    • - Resident training, Pathology in Taipei Veterans General Hospital
    • - Chief resident, Pathology in Taipei Veterans General Hospital
    • - Attending physician, Pathology in Taipei Veterans General Hospital
    • - Instructor, National Yang Ming University
    • - Assoicate Professor, National Yang Ming University
    • - Fellowship in Pathology, Johns Hopkins Hospital
  • Medical Expertise
    1. Genitourinary Pathology
  • License
    Anatomic Pathology Clinical Pathology
  • Language Expertise
    Mandarin, English

[Publications]

  1. Pan CC*; Tseng CE, Kuroda N, Yano M, Yasuda M, Nagashima Y, Yeh YC, Wang YC, Chang YH, Epstein JI. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis. Appl Immunohistochem Mol Morphol. 2022;30:257-263
  2. Pan CC*, Yeh YC, Wang YC, Chang YH. Differential expression analysis of clear cell renal cell carcinomas in The Cancer Genome Atlas distinguishes an aggressive subset enriched with chromosomes 7 and 12 gains. Histopathology 2020;76;950-958.
  3. Pan CC,* Tsuzuki T, Morii E, Fushimi H, Chen PCH, Epstein JI. (2018/6) Whole exome sequencing demonstrates recurrent somatic copy number alterations and sporadic mutations in specialized stromal tumors the prostate. Hum Pathol 2018;76:9-16..
  4. Wu,P.S.; Chang,Y.H.; Pan,C.C.* (2017/12) High expression of heat shock proteins and heat shock factor-1 distinguishes an aggressive subset of clear cell renal cell carcinoma. Histopathology, 2017;71:711-718.
  5. Kao HL; Lai,C.R.; Ho,H.L.; Pan,C.C.* (2016, March) Molecular typing for detection of high-risk human papillomavirus is a useful tool for distinguishing primary bladder carcinoma from secondary involvement of uterine cervical carcinoma in the urinary bladder. Histopathology 2016;68:513-9.
  6. Pan CC*, Yu HJ, Chang YH. (2014, Aug) The prognostic value of combined clinicopathological and biomarker modelling for non-muscle-invasive bladder cancer. Histopathology 2014;65:207-715.
  7. Pan,C.C*; Epstein,J.I. Common chromosomal aberrations detected by array comparative genomic hybridization in specialized stromal tumors of the prostate. Modern Pathology, 26(11):1536-1543.
  8. Pan,C.C*.; Sung,M.T.; Huang,H.Y.; Yeh,K.T. (2013, Jul). High chromosomal copy number alterations in Xp11 translocation renal cell carcinomas detected by array comparative genomic hybridization are associated with aggressive behavior. American Journal of Surgical Pathology, 37(7):1116-1119.
  9. Yu HJ, Chang YH, Pan CC*. Prognostic significance of heat shock proteins in urothelial carcinoma of the urinary bladder. Histopathology. 2013;62:788-798.
  10. Chang WC, Chang YH, Pan CC*. Prognostic significance in substaging of T1 urinary bladder urothelial carcinoma on transurethral resection. Am J Surg Pathol. 2012;36:454-461.
  11. Pan CC,* Epstein JI (2010/12). Detection of Chromosome Copy Number Alterations in Metanephric Adenomas by Array Comparative Genomic Hybridization. MODERN PATHOLOGY 23:1634-1640 (SCI)
  12. Pan CC,* Chang YH, Chen KK, Yu HJ, Sun CH, Ho DMT (2010/10). Constructing Prognostic Model incorporating the 2004 WHO/ISUP Classification for Patients With Non-Muscle-Invasive Urothelial Tumours of the Urinary Bladder. JOURNAL OF CLINICAL PATHOLOGY 63:910-915 (SCI)
  13. Kuroda,N.; Shiotsu,T.; Kawada,C.; Shuin,T.; Hes,O.; Michal,M.; Ohe,C.; Mikami,S.; Pan CC. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Ann Diagn Pathol 2011.15;4:282-285 (SCI))
  14. Pan CC*, Chang YH, Chen KK, Yu HJ, Sun CH, Ho DMT (2010/5). Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am J Clin Pathol 133:788-795 (SCI)
  15. Pan CC, Chen YJ, Chang LC, Chang YH, Ho DMT. (2009/8) Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma. Histopathology 55:145-153 (SCI)
  16. Pan CC, Chung MY, Ng KF et al. (2008/2) Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. J Pathol 214:387-93. (SCI)
  17. Pan CC, Jong YJ, Chai CY, Huang SH, Chen YJ*. (2006/5). Comparative genomic hybridization study of perivascular epithelioid cell tumor: molecular genetic evidence of perivascular epithelioid cell tumor as a distinctive neoplasm. Hum Pathol 37:606-612 (SCI)